Tech Transfer

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

Researchers at UVA are bringing industry partners to the table to create cutting-edge technologies that produce tangible value for society.

Researchers at UVA are bringing industry partners to the table to create cutting-edge technologies that produce tangible value for society.

ITHRIV includes the University of Virginia, Inova Health System, Virginia Tech and Carilion Clinic as partners, with the Center for Open Science and UVA’s Licensing & Ventures Group as affiliates.

University of Virginia School of Medicine professor Lee Ritterband created SHUTi (Sleep Healthy Using the Internet) – a digital therapeutic that uses cutting-edge technology to administer cognitive behavioral therapy for people suffering from insom

Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla

The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 

PsiKick is utilizing revolutionary ultra-low-power technologies from the Universities of Virginia and Michigan to build completely self-powered sensing systems that do not require batteries, can be deployed nearly anywhere, and unlock new data stream

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.